Antiretroviral Therapy

Browse more sub-categories

Resources: 96

Medical Case Management Curriculum

This multi-module curriculum is designed specifically for Medical Case Managers.

Courses within Curriculum

  1. Cultural Awareness Basics
  2. Health Literacy and...
Type
Publication Date
09/15/2017

HIV Resource Library

New England AETC's HIV Resource Library is a compilation of curated resources and education packets on HIV, viral hepatitis, and related public health...

Publication Date
05/27/2021

Prevention IS Care

To help HIV care providers engage patients in care and transmission prevention, the Centers for Disease Control and Prevention (CDC) developed a new a...

Publication Date
06/30/2021

ART Drug Interactions

Training slides review potential ARV drug-drug interactions and identify resources for the evaluation of drug-drug interactions.

Documents with previ...

Publication Date
09/22/2021

IAS Update 2023

Description:

(Recorded 8/9/23)

Presenters provide significant findings and key updates from the 24th International AIDS Conference. 

Speakers:

Kenneth May...

Publication Date
10/11/2023

HIV 101

Training slides review the basics of HIV including history, transmission, testing, and treatment. It provides information about the variety of service...

Publication Date
12/15/2023

NCCC Trainings On Demand

Access recorded trainings presented by the AETC National Clinician Consultation Center (NCCC) in partnership with Health Resources and Services Admini...

Publication Date
12/27/2023

ART Adherence

Description:

This Training Presentation will compare and contrast factors that affect medication adherence and apply a patient centered approach to ant...

Publication Date
01/11/2024

ART Simplification

Training slides list reasons to consider switching antiretroviral (ARV) therapy in virologically suppressed patient according to HHS guidelines, revie...

Publication Date
01/12/2024

Case Based Learning

These training slides guide providers in decision making on managing antiretroviral therapy and switching treatments, as well as discussions on preven...

Publication Date
03/18/2024

HIV Medications 101

These training slides discuss the initial laboratory tests needed in the work-up of a person with a reactive (positive) HIV antigen/antibody test, ant...

Publication Date
03/19/2024

Switching ART Regimens

These training slides discuss the common reasons for switching antiretroviral therapy (ART) regimens, the importance of taking into account relevant p...

Publication Date
04/12/2024

HIV Medications Overview

These guideline slides compare and contrast various antiretroviral therapy (ART) options when initiating treatment for people with HIV, as well as ind...

Publication Date
04/12/2024

Conference Update: CROI 2024

These slides provide an overview on DoxyPEP for sexually transmitted infection (STI) prevention, as well as newest data on novel antiretroviral thera...

Publication Date
05/13/2024

ART in Renal Failure

These slides provide information on causes of creatinine elevation in people with HIV (PWH), workup of creatinine elevation, as well as the effects of...

Publication Date
05/31/2024

Current Topics in HIV

These slides provide various topics related to HIV, such as testing and linkage to care, options for post-exposure prophylaxis (PEP) treatment, curren...

Publication Date
06/03/2024

Resources: 8

CROI 2022 Update

Training slides provide an update on the epidemiology of HIV in the U.S., antiretrovirals, PrEP, the HIV “cure” case, COVID-19 prevention & treatm...

Publication Date
04/28/2022

Articles: 23

Cobicistat and Stribild Use in Patients with Renal Insufficiency

Co-Author: Susa Coffey, MD; Medical Editor, AETC National Resource Center

An open-label study is evaluating the renal safety of elvitegravir/cobicistat/emtricitabine/tenofovir (Stribild, or the "quad" pill) and cobicistat. For those patients with mild-to-moderate renal impairment (estimated glomerula...

Ian
McNicholl

Darunavir/Cobicistat/FTC/TAF Single-Pill Combination in Treatment-Experienced Patients: EMERALD Study

The EMERALD Study is a Phase III, open-label, noninferiority study in which 1,141 patients with stable HIV suppression on a regimen comprising a boosted protease inhibitor plus TDF/FTC were randomized (2:1) to either switch to an investigational single-tablet regimen containing darunavir 800 mg/cobi...

Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)

Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain inter...